VIX001

Neobiosis, LLC · Phase 1 active Small molecule

At a glance

Generic name	VIX001
Also known as	Purified Amniotic Fluid
Sponsor	Neobiosis, LLC
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Safety, Efficacy, and Dosing of VIX001 in Patients With Neurological Symptoms of Post Acute COVID-19 Syndrome (PACS). (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

VIX001 CI brief — competitive landscape report
VIX001 updates RSS · CI watch RSS
Neobiosis, LLC portfolio CI